Harvest Group Wealth Management, LLC Corcept Therapeutics Inc Transaction History

Harvest Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$23.49 - $30.56 $328 - $427	-14 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$10.11 - $14.04 $1,314 - $1,825	-130 Reduced 90.28%	14 $0
Q2 2019 Jul 31, 2019	BUY	$9.78 - $12.76 $185 - $242	19 Added 15.2%	144 $1,000
Q1 2019 May 06, 2019	BUY	$10.03 - $15.71 $1,253 - $1,963	125 New	125 $1,000

316

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.22B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.